友邦(01299.HK)完成收購中郵保險24.99%股權
友邦(01299.HK)公布,其已完成對中國郵政子公司「中郵保險」的投資。該投資在獲得所有必要的監管批准、公司全資附屬公司友邦保險投資120.33億元人民幣認購中郵保險24.99%股權後完成。集團運營的友邦中國將完全獨立於此次投資。
中郵保險通過其與郵儲銀行(01658.HK)的分銷合作關係,可觸達全國約4萬個金融網點以及超過6億名零售客戶。中郵保險目前在21個省份銷售產品,覆蓋郵儲銀行分銷網絡的80%w。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.